18362144 19482226 21844169 20889486 33599945 24423640 35994827 19815012 19679562 28620835 22291444 28975445 23220386 30937395 28169962 22057787 28768533 30990467 19610108 24532983 21568911 33694021 24058416 36691076 30995519 21187721 26477883 1824861 - Search Results

Year	Number of Results
2008	3
2009	8
2010	11
2011	9
2012	7
2013	4
2014	6
2015	4
2016	2
2017	6
2018	2
2019	5
2020	3
2021	5
2022	1
2023	1

1

Aberrant folding of pathogenic Parkin mutants: aggregation versus degradation.

Schlehe JS, Lutz AK, Pilsl A, Lämmermann K, Grgur K, Henn IH, Tatzelt J, Winklhofer KF. Schlehe JS, et al. J Biol Chem. 2008 May 16;283(20):13771-9. doi: 10.1074/jbc.M707494200. Epub 2008 Mar 24. J Biol Chem. 2008. PMID: 18362144 Free article.

2

Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects.

Ferrer I. Ferrer I. Prog Neurobiol. 2009 Jun;88(2):89-103. doi: 10.1016/j.pneurobio.2009.02.004. Epub 2009 Mar 9. Prog Neurobiol. 2009. PMID: 19482226 Review.

3

Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis.

Bosco DA, LaVoie MJ, Petsko GA, Ringe D. Bosco DA, et al. Cold Spring Harb Perspect Biol. 2011 Oct 1;3(10):a007500. doi: 10.1101/cshperspect.a007500. Cold Spring Harb Perspect Biol. 2011. PMID: 21844169 Free PMC article. Review.

4

Molecular chaperone-mediated rescue of mitophagy by a Parkin RING1 domain mutant.

Rose JM, Novoselov SS, Robinson PA, Cheetham ME. Rose JM, et al. Hum Mol Genet. 2011 Jan 1;20(1):16-27. doi: 10.1093/hmg/ddq428. Epub 2010 Oct 1. Hum Mol Genet. 2011. PMID: 20889486 Free PMC article.

5

Cellular and molecular pathophysiology in the progression of Parkinson's disease.

Zaman V, Shields DC, Shams R, Drasites KP, Matzelle D, Haque A, Banik NL. Zaman V, et al. Metab Brain Dis. 2021 Jun;36(5):815-827. doi: 10.1007/s11011-021-00689-5. Epub 2021 Feb 18. Metab Brain Dis. 2021. PMID: 33599945 Free PMC article. Review.

6

Long-term overexpression of human wild-type and T240R mutant Parkin in rat substantia nigra induces progressive dopaminergic neurodegeneration.

Van Rompuy AS, Lobbestael E, Van der Perren A, Van den Haute C, Baekelandt V. Van Rompuy AS, et al. J Neuropathol Exp Neurol. 2014 Feb;73(2):159-74. doi: 10.1097/NEN.0000000000000039. J Neuropathol Exp Neurol. 2014. PMID: 24423640

7

Rab11 regulates mitophagy signaling pathway of Parkin and Pink1 in the Drosophila model of Parkinson's disease.

Rai P, Roy JK. Rai P, et al. Biochem Biophys Res Commun. 2022 Oct 20;626:175-186. doi: 10.1016/j.bbrc.2022.08.027. Epub 2022 Aug 12. Biochem Biophys Res Commun. 2022. PMID: 35994827

8

The effects of parkin suppression on the behaviour, amyloid processing, and cell survival in APP mutant transgenic mice.

Perucho J, Casarejos MJ, Rubio I, Rodriguez-Navarro JA, Gómez A, Ampuero I, Rodal I, Solano RM, Carro E, García de Yébenes J, Mena MA. Perucho J, et al. Exp Neurol. 2010 Jan;221(1):54-67. doi: 10.1016/j.expneurol.2009.09.029. Epub 2009 Oct 6. Exp Neurol. 2010. PMID: 19815012

9

Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release.

Berger AK, Cortese GP, Amodeo KD, Weihofen A, Letai A, LaVoie MJ. Berger AK, et al. Hum Mol Genet. 2009 Nov 15;18(22):4317-28. doi: 10.1093/hmg/ddp384. Epub 2009 Aug 13. Hum Mol Genet. 2009. PMID: 19679562 Free PMC article.

10

Twenty years since the discovery of the parkin gene.

Hattori N, Mizuno Y. Hattori N, et al. J Neural Transm (Vienna). 2017 Sep;124(9):1037-1054. doi: 10.1007/s00702-017-1742-7. Epub 2017 Jun 15. J Neural Transm (Vienna). 2017. PMID: 28620835 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results